65,437 trials
Chest Pain · Acute Coronary Syndrome · Acute Myocardial Infarction
Primary: Rates of Major Cardiac Events (AMI or Cardiac Death) Within 30 Days — 0; 0; 0; 10 Participants
Cancer Survivors
Primary: Validation - 30-second Chair Stand Test — 0.33 chair stands
Solid Tumors
Primary: Number of Participants With First Cycle Dose Limiting Toxicities (DLTs) — 0; 0; 0; 2 Participants
Cirrhosis · Ascites · Liver Diseases
Primary: Overall Participant Retention Rate Based on Proportion of Participants Who Complete All Study Visits — 10 Participants
Healthy
Primary: Number of Subjects With Drug-related Adverse Events (AEs) — 0; 0; 0; 0 Participants
Acute Myeloid Leukemia
Primary: Feasibility (Recruitment Rates) — 11 Participants
Onychomycosis
Primary: Human Factors — 15 participants
Anxiety · Burden, Dependency · Caregiver
Primary: Anxiety Symptoms, as Measured by PROMIS Anxiety Short Form — 55.51; 53.93; 56.75; 57.35 T-score
Small Cell Lung Cancer
Primary: Number of Participants With Adverse Events (AEs) — 7; 6; 29; 35 Participants
Rotator Cuff Tear Arthropathy
Primary: Postoperative External Range of Motion (ROM) — 35; 39 degrees
Quadratus Lumborum Block · Surgical Wound Infiltration
Primary: Opioid Consumption in Oral Morphine Milliequivalents for the First 24 Hours After Surgery (Defined as 24 Hours After the Anesthesia End Time) — 17.50; 21.25 oral…
Infections, Meningococcal
Primary: Percentage of Blood Samples Without Bactericidal Serum Activity Against Each of the Endemic US N. Meningitidis Serogroup B Strains at 1 Month After the 3-dose (0,2,6-M)…
HIV-1-infection
Primary: Viral Suppression — 100 percentage of participants
Sepsis
Primary: Door-to-antibiotic Time — 160; 146; 139; 140 minutes — p=<0.001
Malaria · Seizures · Coma
Primary: Mean Maximum Temperature — 38.6; 39.2 degrees of Celsius — p=<0.0001